181 related articles for article (PubMed ID: 35528180)
1. The Significance of Tumor Microenvironment Score for Breast Cancer Patients.
Tian Y; Wang J; Wen Q; Gao A; Huang A; Li R; Zhang Y; Su G; Sun Y
Biomed Res Int; 2022; 2022():5673810. PubMed ID: 35528180
[TBL] [Abstract][Full Text] [Related]
2. Tumor microenvironment characterization in colorectal cancer to identify prognostic and immunotherapy genes signature.
Guo XW; Lei RE; Zhou QN; Zhang G; Hu BL; Liang YX
BMC Cancer; 2023 Aug; 23(1):773. PubMed ID: 37596528
[TBL] [Abstract][Full Text] [Related]
3. Improving ovarian cancer treatment decision using a novel risk predictive tool.
Xu Z; Song J; Cao L; Rong Z; Zhang W; He J; Li K; Hou Y
Aging (Albany NY); 2022 Apr; 14(8):3464-3483. PubMed ID: 35439731
[TBL] [Abstract][Full Text] [Related]
4. Tumor microenvironment characterization in cervical cancer identifies prognostic relevant gene signatures.
Peng L; Hayatullah G; Zhou H; Chang S; Liu L; Qiu H; Duan X; Han L
PLoS One; 2021; 16(4):e0249374. PubMed ID: 33901225
[TBL] [Abstract][Full Text] [Related]
5. Tumor Microenvironment Characterization in Glioblastoma Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures.
Zhang J; Xiao X; Zhang X; Hua W
J Mol Neurosci; 2020 May; 70(5):738-750. PubMed ID: 32006162
[TBL] [Abstract][Full Text] [Related]
6. Tumor Microenvironment Analysis Identified Subtypes Associated With the Prognosis and the Tumor Response to Immunotherapy in Bladder Cancer.
Zhang H; Song J; Dong J; Liu Z; Lin L; Wang B; Ma Q; Ma L
Front Genet; 2021; 12():551605. PubMed ID: 33732281
[No Abstract] [Full Text] [Related]
7. Identifying prognostic signatures in the microenvironment of prostate cancer.
Lu G; Cai W; Wang X; Huang B; Zhao Y; Shao Y; Wang D
Transl Androl Urol; 2021 Nov; 10(11):4206-4218. PubMed ID: 34984186
[TBL] [Abstract][Full Text] [Related]
8. Prognosis of Tumor Microenvironment in Luminal B-Type Breast Cancer.
Lv J; Ren J; Zheng J; Zhang F; Han M
Dis Markers; 2022; 2022():5621441. PubMed ID: 35242245
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Tumor Microenvironment in Lung Adenocarcinoma Identifies Immune Signatures to Predict Clinical Outcomes and Therapeutic Responses.
Chen D; Wang Y; Zhang X; Ding Q; Wang X; Xue Y; Wang W; Mao Y; Chen C; Chen Y
Front Oncol; 2021; 11():581030. PubMed ID: 33747907
[TBL] [Abstract][Full Text] [Related]
10. Tumor microenvironment evaluation promotes precise checkpoint immunotherapy of advanced gastric cancer.
Zeng D; Wu J; Luo H; Li Y; Xiao J; Peng J; Ye Z; Zhou R; Yu Y; Wang G; Huang N; Wu J; Rong X; Sun L; Sun H; Qiu W; Xue Y; Bin J; Liao Y; Li N; Shi M; Kim KM; Liao W
J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34376552
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Genomic Characterization of Tumor Microenvironment and Relevant Signature in Clear Cell Renal Cell Carcinoma.
Zhang C; Qi F; Zheng Y; Xia X; Li X; Wang X
Front Oncol; 2022; 12():749119. PubMed ID: 35651807
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the Tumor Microenvironment in Osteosarcoma Identifies Prognostic- and Immunotherapy-Relevant Gene Signatures.
Tan J; Feng X; Wu H; Yang B; Shi M; Xie C; Su Z; Li L; Luo M; Zuo Z; Zhu S; Yang J; Lin L
J Immunol Res; 2022; 2022():6568278. PubMed ID: 36065454
[TBL] [Abstract][Full Text] [Related]
13. Novel immune-related genes in the tumor microenvironment with prognostic value in breast cancer.
Tan W; Liu M; Wang L; Guo Y; Wei C; Zhang S; Luo C; Liu N
BMC Cancer; 2021 Feb; 21(1):126. PubMed ID: 33549054
[TBL] [Abstract][Full Text] [Related]
14. The tumor microenvironment in gastrointestinal adenocarcinomas revealed a prognostic and immunotherapeutic biomarker.
Zhang Y; Li L; Chu F; Zhang L; Zhang L; Wu H; Li K
Aging (Albany NY); 2022 Dec; 14(24):10171-10216. PubMed ID: 36585927
[TBL] [Abstract][Full Text] [Related]
15. Tumor Microenvironment Characterization in Gastric Cancer Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures.
Zeng D; Li M; Zhou R; Zhang J; Sun H; Shi M; Bin J; Liao Y; Rao J; Liao W
Cancer Immunol Res; 2019 May; 7(5):737-750. PubMed ID: 30842092
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the Immune Cell Infiltration Landscape Uncovers Prognostic and Immunogenic Characteristics in Lung Adenocarcinoma.
Wang X; Xu Z; Liu Z; Lin W; Cao Z; Feng X; Gao Y; He J
Front Genet; 2022; 13():902577. PubMed ID: 35677561
[TBL] [Abstract][Full Text] [Related]
17. Tumor microenvironment characterization in head and neck cancer identifies prognostic and immunotherapeutically relevant gene signatures.
Huo M; Zhang Y; Chen Z; Zhang S; Bao Y; Li T
Sci Rep; 2020 Jul; 10(1):11163. PubMed ID: 32636465
[TBL] [Abstract][Full Text] [Related]
18. Leveraging Tumor Microenvironment Infiltration in Pancreatic Cancer to Identify Gene Signatures Related to Prognosis and Immunotherapy Response.
Yang J; Zeng L; Chen R; Huang L; Wu Z; Yu M; Zhou Y; Chen R
Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900234
[TBL] [Abstract][Full Text] [Related]
19. Landscape of Immune Microenvironment Under Immune Cell Infiltration Pattern in Breast Cancer.
Xu Q; Chen S; Hu Y; Huang W
Front Immunol; 2021; 12():711433. PubMed ID: 34512634
[TBL] [Abstract][Full Text] [Related]
20. A four-gene signature in the tumor microenvironment that significantly associates with the prognosis of patients with breast cancer.
Wang J; Yang Z; Zhang C; Ouyang J; Zhang G; Wu C
Gene; 2020 Nov; 761():145049. PubMed ID: 32791092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
